Relapsed or Refractory Pediatric Malignant Solid Tumors (Including Neuroblastoma, Rhabdomyosarcoma, Ewing Sarcoma, Osteosarcoma)
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Liposomal Irinotecan, Vincristine, Temozolomide, and Anlotinib for R/R Pediatric Solid Tumors (NCT07444918) | Tianjin Medical University Cancer Institute and Hospital | 2026-03-01 |
Track Relapsed or Refractory Pediatric Malignant Solid Tumors (Including Neuroblastoma, Rhabdomyosarcoma, Ewing Sarcoma, Osteosarcoma) automatically
Every clearance here is in the API, with alerts when new ones post.